Literature DB >> 213537

Myasthenia in patients with dermatomyositis: clinical, electrophysiological and ultrastructural studies.

Constantin Vasilescu, G Bucur, A Petrovici, A Florescu.   

Abstract

In 4 patients with clinical signs of dermatomyositis, confirmed by electromyography and muscle biopsy, a form of muscle fatigue was detected which was expressed clinically by predominantly proximal motor deficit, with phonation and deglutition disturbances, slightly influenced by prostigmine. In all patients, stimulation of the ulnar nerve at 3--10 Hz induced a decrement of muscle-evoked potentials in abductor digiti minimi and at 15--50 Hz an increment at the end of the trains (1.2 sec in duration) of repetitive stimulation (preceded in two cases by a decrement in the response to the fifth stimulus in the train). Stimulation at 30 Hz for 10 sec resulted in a transient facilitation, followed (at 3 Hz stimulation) by postactivation exhaustion which disappeared after 5--15 min. The post-tetanic facilitation, the incremental response and the myasthenic symptoms reverted to normal under treatment with corticosteroids, an immunosuppressor agent and guanidine hydrochloride. A mixed, pre- and postsynaptic mechanism is presumed to underlie the muscle fatigue in our patients. Electron microscopy of muscle biopsies disclosed zones of necrosis and, in incipient stages, large agglomerations of glycogen that had disorganized the structure of myofibrils. The end-plates in the biopsies were larger than normal and the cholinesterase reaction was hyperactive. Serum immunoelectrophoretic and electrophoretic data--increase of IgG and IgM, decrease of IgA and hypergammaglobulinaemia -- point to a possible autoimmune mechanism of the neuromuscular disorders in our patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213537     DOI: 10.1016/0022-510x(78)90060-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  The co-existence of myasthenia gravis in patients with myositis: a case series.

Authors:  Julie J Paik; Andrea M Corse; Andrew L Mammen
Journal:  Semin Arthritis Rheum       Date:  2013-12-18       Impact factor: 5.532

2.  Peripheral neuropathy with a syndrome of continuous motor unit activity.

Authors:  C Vasilescu; A Florescu
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

3.  Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders.

Authors:  W M Behan; P O Behan; D Doyle
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

Review 4.  Current approach to seronegative myasthenia.

Authors:  Zohar Argov
Journal:  J Neurol       Date:  2010-09-18       Impact factor: 4.849

5.  Complex neuromuscular disorder in a patient with chronic myeloid leukaemia.

Authors:  P S Bergin; A N Gale
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

6.  Clinical and electrophysiological study of neuropathy after organophosphorus compounds poisoning.

Authors:  C Vasilescu; A Florescu
Journal:  Arch Toxicol       Date:  1980-02       Impact factor: 5.153

7.  Voluntary activation failure is detectable in some myositis patients with persisting quadriceps femoris weakness: an observational study.

Authors:  Catherine B Molloy; Ahmed O Al-Omar; Kathryn T Edge; Robert G Cooper
Journal:  Arthritis Res Ther       Date:  2006-04-10       Impact factor: 5.156

8.  Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome.

Authors:  Stéphane Mathis; Laurent Magy; Philippe Corcia; Karima Ghorab; Laurence Richard; Jonathan Ciron; Mathilde Duchesne; Jean-Michel Vallat
Journal:  Case Rep Neurol Med       Date:  2016-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.